EMEA-000433-PIP01-08
Key facts
| Active substance |
Dirucotide acetate
|
| Therapeutic area |
Neurology
|
| Decision number |
P/43/2009
|
| PIP number |
EMEA-000433-PIP01-08
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Multiple Sclerosis
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|